David Hartenbaum, MD
Advertisement
Articles by David Hartenbaum, MD
Advertisement
Latest Updated Articles
- Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products
Published: February 1st 1996 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
AI-Supported Mammography Caught More Cancers During Screening
2
Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026
3
The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine
4
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
5
